Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- KISSEI PHARMA
- Publication Date
- 2020-04-10
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to methods for determining the dosing regimen of a gonadotropin releasing hormone antagonist for use in the treatment of endometriosis. Background technique
[0002] Endometriosis is an estrogen-dependent gynecological condition characterized by the presence of endometrium-like tissue on the outside of the uterus and is one of the most common sex hormone-dependent diseases. The condition is mainly observed in women of reproductive age and disappears spontaneously after menopause. A chronic inflammatory response caused by ectopic endometrial cells Endometriosis can lead to infertility and a variety of painful symptoms, including dysmenorrhea, dyspareunia, chronic pelvic pain, and difficulty urinating and defecating.
[0003] The main goal of treating endometriosis is to achieve symptom relief. Treatment options for women with endometriosis-related pain are diverse and include analgesic therapy, hormone therapy, conservati...